Actelion (now Janssen Pulmonary Hypertension) logo

Actelion (now Janssen Pulmonary Hypertension) Employee Directory

Pharmaceutical ManufacturingBasel-Stadt, Switzerland201-500 Employees

Actelion, now known as Janssen Pulmonary Hypertension, operates in the pharmaceutical manufacturing industry and is based in Basel, Basel-Stadt, Switzerland. It is part of Janssen, a Johnson & Johnson company, with updates provided on Janssen's LinkedIn channel. The organization employs 201 to 500 people and maintains a web presence at https://janssen.com. The name Janssen Pulmonary Hypertension indicates its integration into Janssen's portfolio related to pulmonary hypertension. Publicly reported recent news shows Janssen Pharmaceuticals, Inc. engaging in external research collaborations with multiple partners, illustrating the kind of activity associated with the Janssen organization.

Find Actelion (now Janssen Pulmonary Hypertension) employees' phone numbers or email addresses

Actelion (now Janssen Pulmonary Hypertension) Global Highlights

Location
Employees

Europe
571

Minus sign iconPlus sign icon
  • Switzerland
    354
  • France
    79
  • United Kingdom Of Great Britain And Northern Ireland
    34
  • Italy
    26
  • Germany
    15
  • Greece
    10
  • Belgium
    9
  • Spain
    7
  • Netherlands
    7
  • Sweden
    7
  • Poland
    6
  • Austria
    5
  • Portugal
    5
  • Hungary
    3
  • Malta
    1
  • Romania
    1
  • Finland
    1
  • Ireland
    1

North America
272

Minus sign iconPlus sign icon
  • United States Of America
    240
  • Mexico
    16
  • Canada
    15
  • Panama
    1

Asia
85

Minus sign iconPlus sign icon
  • Japan
    27
  • Turkey
    20
  • China
    15
  • Israel
    7
  • Russian Federation
    5
  • India
    4
  • Singapore
    3
  • United Arab Emirates
    1
  • Malaysia
    1
  • Indonesia
    1
  • Iran
    1

South America
14

Minus sign iconPlus sign icon
  • Brazil
    12
  • Chile
    1
  • Argentina
    1

Oceania
8

Minus sign iconPlus sign icon
  • Australia
    8

Africa
3

Minus sign iconPlus sign icon
  • Morocco
    1
  • Egypt
    1
  • Mauritius
    1

Actelion (now Janssen Pulmonary Hypertension)'s Leadership

  • Vice President Medical Science Expert at Actelion (now Janssen Pulmonary Hypertension)
    M. B.
    Vice President Medical Science Expert
  • Vice President Head Of Business & Science Affairs at Actelion (now Janssen Pulmonary Hypertension)
    M. H. W.
    Vice President Head Of Business & Science Affairs
  • President at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    President
  • Head Global Clinical Monitoring at Actelion (now Janssen Pulmonary Hypertension)
    C. S.
    Head Global Clinical Monitoring
  • Head Of Clinical Science Early Projects at Actelion (now Janssen Pulmonary Hypertension)
    S. R.
    Head Of Clinical Science Early Projects
  • Head Global Clinical Development at Actelion (now Janssen Pulmonary Hypertension)
    G. B.
    Head Global Clinical Development
  • Head Of Clinical Development at Actelion (now Janssen Pulmonary Hypertension)
    J. H. P.
    Head Of Clinical Development
  • Head Medical Safety Surveilance at Actelion (now Janssen Pulmonary Hypertension)
    C. V.
    Head Medical Safety Surveilance

Actelion (now Janssen Pulmonary Hypertension) Employee Metrics

100%
50%
0%
2026
2025
  • Customer Success
  • Research
  • Program & Project Management
  • Operations
  • Sales
  • Other
  • Engineering
  • Administrative
  • Biotechnology
  • Healthcare Services
  • Legal

Contact profiles from Actelion (now Janssen Pulmonary Hypertension)

Name
Title
Contact
Location
Last Update
  • Responsible Person Ch (fvp) at Actelion (now Janssen Pulmonary Hypertension)
    P. L.
    Responsible Person Ch (fvp)
    Germany
    Aug 04, 2026
  • Cofounder at Actelion (now Janssen Pulmonary Hypertension)
    W. F.
    Cofounder
    Switzerland
    Aug 07, 2026
  • President at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    President
    Japan
    Aug 30, 2026
  • Owner at Actelion (now Janssen Pulmonary Hypertension)
    S. A.
    Owner
    Brazil, Sao Paulo
    Mar 05, 2024
  • Senior Director, Clinical Science Pediatrics Program Head at Actelion (now Janssen Pulmonary Hypertension)
    C. L.
    Senior Director, Clinical Science Pediatrics Program Head
    Switzerland, Basel-City
    Sep 02, 2026
  • Head Global Clinical Monitoring at Actelion (now Janssen Pulmonary Hypertension)
    C. S.
    Head Global Clinical Monitoring
    Switzerland
    May 27, 2025
  • Senior Assistant To The Vp Head Global Medical Affairs And The Gma Team at Actelion (now Janssen Pulmonary Hypertension)
    D. R.
    Senior Assistant To The Vp Head Global Medical Affairs And The Gma Team
    Switzerland
    Sep 10, 2026
  • Head Of Clinical Science Early Projects at Actelion (now Janssen Pulmonary Hypertension)
    S. R.
    Head Of Clinical Science Early Projects
    Switzerland
    Sep 02, 2026
  • Vice-President, Head Clinical Pharmacology at Actelion (now Janssen Pulmonary Hypertension)
    J. D.
    Vice-President, Head Clinical Pharmacology
    Switzerland
    Mar 07, 2026
  • Vice President Medical Science Expert at Actelion (now Janssen Pulmonary Hypertension)
    M. B.
    Vice President Medical Science Expert
    France, Paris
    Sep 02, 2026

Frequently Asked Questions

What is Actelion (now Janssen Pulmonary Hypertension) known for?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) operates in the Pharmaceutical Manufacturing industry. You can contact Actelion (now Janssen Pulmonary Hypertension)'s main corporate office by phone at . Explore Actelion (now Janssen Pulmonary Hypertension)'s company overview page for more information.

What is Actelion (now Janssen Pulmonary Hypertension)'s most common email format?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) employees' email format typically follows the pattern of First.Last@actelion.com. Trying to find reliable and up-to-date employee contact data? Find more Actelion (now Janssen Pulmonary Hypertension) email formats with LeadIQ.

How many employees does Actelion (now Janssen Pulmonary Hypertension) have currently?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) has approximately 458 employees as of August 2026. These team members are located across 6 continents, including Europe, North America and Asia.

Who are Actelion (now Janssen Pulmonary Hypertension)'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Actelion (now Janssen Pulmonary Hypertension)'s key employees include:

  • Vice President Medical Science Expert: M. B.
  • Vice President Head Of Business & Science Affairs: M. H. W.
  • President: S. T.
  • Head Global Clinical Monitoring: C. S.
  • Head Of Clinical Science Early Projects: S. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.